Clinical Study Of Yiqi Solid Moxibustion In The Treatment Of Chronic Obstructive Pulmonary Disease In Elderly Stable Lung And Kidney Qi Deficiency

Objective:In this project,Yiqi Solid Moxibustion combined with Western medicine was used to treat chronic obstructive pulmonary disease(COPD)with stable lung and kidney qi deficiency in the elderly,taking lung function as the main observation index,observing the clinical efficacy of moxibustion,and exploring new clinical treatment methods,so as to provide patients with a safer,more effective and convenient treatment method.Content:Based on the Guidelines for the Diagnosis and Treatment of COPD(2021 Revised Edition),the diagnostic criteria of this study were based on the Guidelines for the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease(2021 Revised Edition),and a total of 72 patients were included in the study.All subjects were patients who attended the inpatient or outpatient department of the Department of Respiratory Medicine of Rizhao People’s Hospital from December 2021 to December 2022,and met the criteria for inclusion.Seventy-two participants were randomized into treatment and control groups of 36 in each group.The two groups of patients were given conventional treatment with western medicine at the same time,and the treatment group added Yiqi and moxibustion treatment on this basis.Lung function(FEV1/FVC,FEV1%)were taken as the main observation indexes,and the quality of life self-assessment(CAT score)and TCM syndrome score of COPD patients were used as secondary observation indicators,and the data were statistically analyzed before and after treatment.The effects of this study were assessed as follows:1.Taking lung function as the observation index,compare the data before and after treatment of the two groups within the group,compare the data after treatment between the two groups,and analyze the difference between the treatment group and the control group in improving the lung function of patients.2.Taking the self-assessment(CAT score)of COPD patients as an observation index,the data before and after treatment of the two groups were compared,and the differences in improving the quality of life of patients between the two groups were analyzed.3.Taking the TCM syndrome score as the observation index,the data before and after treatment of the two groups were compared,and the differences between the two groups in improving the TCM clinical syndrome were analyzed.4.Compare the total effective clinical efficacy of the two groups,and comprehensively analyze the differences in clinical efficacy between the two groups.Results:A total of 67 cases were clinically observed,with 34 in the treatment group and 33 in the control group.1.There were significant differences in FEV1/FVC between the two groups before and after treatment(P<0.05),and there were significant differences in FEV1%between the two groups(P<0.05).There were significant differences in quality of life CAT score and TCM syndrome score between the two groups(P<0.05).After treatment,the difference in total score of TCM symptoms and quality of life CAT score of pulmonary function FEV1%was statistically significant(P<0.05),and the difference in pulmonary function FEV1/FVC was not statistically significant(P>0.05).After treatment,the total score of TCM symptoms,quality of life CAT score,and pulmonary function FEV1%were statistically significant(P<0.05),while the difference in pulmonary function FEV1/FVC was not statistically significant(P>0.05).2.According to the evaluation criteria of pulmonary function efficacy,15 cases were effective in the treatment group,6 cases were effective,and 13 cases were ineffective,with a total effective rate of 61.8%.The control group showed effective 13 cases,effective 3 cases,and ineffective 17 cases,with a total effective rate of 48.5%,and there was no significant difference in total effective rate between the treatment group and the control group(P>0.05).3.According to the criteria for judging the efficacy of TCM symptoms,there were 34 cases in the treatment group,including 14 cases of clinical control,10 cases of obvious effect,6 cases of effective and 4 cases of ineffectiveness,with a total effective rate of 88.2%.There were 33 cases in the control group,4 cases in clinical control,6 cases with obvious effect,15 cases effective and 8 cases ineffective,with a total effective rate of 75.8%,and the total effective rate difference between the treatment group and the control group was statistically significant(P<0.05).Conclusion:To a certain extent,Yiqi solid moxibustion can improve the lung function of elderly patients with stable pulmonary and renal qi deficiency chronic obstructive pulmonary disease,reduce clinical symptoms,and improve the quality of life of elderly patients with stable pulmonary and renal qi deficiency COPD,which is worthy of clinical promotion.